59 related articles for article (PubMed ID: 29742092)
1. Management of chronic lymphocytic leukemia.
Ghia P; Hallek M
Haematologica; 2014 Jun; 99(6):965-72. PubMed ID: 24881042
[TBL] [Abstract][Full Text] [Related]
2. Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide.
Molica S; Rossi M; Allsup D
Acta Haematol; 2024; 147(3):257-259. PubMed ID: 37549650
[TBL] [Abstract][Full Text] [Related]
3. Social deprivation independently impacts clinical outcomes in patients with chronic lymphocytic leukemia.
Fegan G; Tod D; Downing A; Elmusharaf N; Pepper C; Fegan C
Haematologica; 2024 May; 109(5):1566-1569. PubMed ID: 38268485
[No Abstract] [Full Text] [Related]
4. Chronic Lymphocytic Leukemia: Time to Care for the Survivors.
Fedele PL; Opat S
J Clin Oncol; 2024 Jun; 42(17):2005-2011. PubMed ID: 38489567
[No Abstract] [Full Text] [Related]
5. Evolving Frontline Treatment in Chronic Lymphocytic Leukemia.
Coutre SE
Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 8):5-6. PubMed ID: 27168203
[No Abstract] [Full Text] [Related]
6. Highlights in the treatment of chronic lymphocytic leukemia from the 2013 meeting of the American Society of Hematology.
Molica S
Expert Rev Hematol; 2014 Apr; 7(2):187-90. PubMed ID: 24617332
[TBL] [Abstract][Full Text] [Related]
7. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
Awan FT
Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
[No Abstract] [Full Text] [Related]
8. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
Davids MS
Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
[No Abstract] [Full Text] [Related]
9. Highlights in chronic lymphocytic leukemia from the 60th American Society of Hematology Annual Meeting: commentary.
O'Brien SM
Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 1(1):20-23. PubMed ID: 31545308
[No Abstract] [Full Text] [Related]
10. Developments in the treatment of lymphoproliferative disorders: rising to the new challenges of CLL therapy. A report of a symposium presented during the 48th American Society of Hematology Annual Meeting and Exposition, December 8, 2006, Orlando, Florida.
Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 5):1-14; quiz 15-6. PubMed ID: 17519887
[No Abstract] [Full Text] [Related]
11. Highlights in chronic lymphocytic leukemia from the 2017 American Society of Hematology Annual Meeting: commentary.
O'Brien SM
Clin Adv Hematol Oncol; 2018 Jan; 16 Suppl 2(1):16-19. PubMed ID: 29742092
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
